Author Correction: High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade

Affiliations

• ¹ Genentech, San Francisco, CA, USA.
• ² Roche Products Ltd., Welwyn Garden City, UK.
• ³ Netherlands Cancer Institute, Amsterdam, the Netherlands.
• ⁴ Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ⁵ Beth Israel Deaconess Medical Center, Boston, MA, USA.
• ⁶ Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK.
• ⁷ Genentech, San Francisco, CA, USA. huseni.mahrukh@gene.com.
• ⁸ Genentech, San Francisco, CA, USA. mariathasan.sanjeev@gene.com.